Intuitive Surgical, Inc. (ISRG)
USD 526.47
(-3.43%)
USD 526.47
(-3.43%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.22 Billion USD | 36.65% |
| 2022 | 893.2 Million USD | 52.14% |
| 2021 | 587.1 Million USD | -2.39% |
| 2020 | 601.5 Million USD | 1.01% |
| 2019 | 595.5 Million USD | 45.6% |
| 2018 | 409 Million USD | 69.57% |
| 2017 | 241.2 Million USD | 32.31% |
| 2016 | 182.3 Million USD | 8.58% |
| 2015 | 167.9 Million USD | -7.59% |
| 2014 | 181.7 Million USD | 1.17% |
| 2013 | 179.6 Million USD | 47.82% |
| 2012 | 121.5 Million USD | 8.39% |
| 2011 | 112.1 Million USD | 29.15% |
| 2010 | 86.8 Million USD | 50.69% |
| 2009 | 57.6 Million USD | -9.23% |
| 2008 | 63.46 Million USD | 95.77% |
| 2007 | 32.41 Million USD | 33.43% |
| 2006 | 24.29 Million USD | 60.15% |
| 2005 | 15.17 Million USD | 154.27% |
| 2004 | 5.96 Million USD | -32.11% |
| 2003 | 8.78 Million USD | 0.57% |
| 2002 | 8.73 Million USD | 41.35% |
| 2001 | 6.18 Million USD | 1.74% |
| 2000 | 6.07 Million USD | 112.37% |
| 1999 | 2.86 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.38 Billion USD | 6.51% |
| 2024 Q1 | 1.29 Billion USD | 6.45% |
| 2024 Q3 | 1.48 Billion USD | 7.07% |
| 2023 Q3 | 1.14 Billion USD | 14.16% |
| 2023 Q4 | 1.22 Billion USD | 6.37% |
| 2023 FY | 1.22 Billion USD | 36.65% |
| 2023 Q1 | 946.6 Million USD | 5.98% |
| 2023 Q2 | 1 Billion USD | 6.19% |
| 2022 FY | 893.2 Million USD | 52.14% |
| 2022 Q3 | 837.1 Million USD | 15.62% |
| 2022 Q1 | 653 Million USD | 11.22% |
| 2022 Q4 | 893.2 Million USD | 6.7% |
| 2022 Q2 | 724 Million USD | 10.87% |
| 2021 Q1 | 576.8 Million USD | -4.11% |
| 2021 FY | 587.1 Million USD | -2.39% |
| 2021 Q2 | 569.7 Million USD | -1.23% |
| 2021 Q3 | 584.9 Million USD | 2.67% |
| 2021 Q4 | 587.1 Million USD | 0.38% |
| 2020 Q1 | 620.3 Million USD | 4.16% |
| 2020 Q4 | 601.5 Million USD | -9.26% |
| 2020 Q3 | 662.9 Million USD | 2.7% |
| 2020 Q2 | 645.5 Million USD | 4.06% |
| 2020 FY | 601.5 Million USD | 1.01% |
| 2019 Q4 | 595.5 Million USD | 2.74% |
| 2019 Q3 | 579.6 Million USD | 13.03% |
| 2019 FY | 595.5 Million USD | 45.6% |
| 2019 Q1 | 468.3 Million USD | 14.5% |
| 2019 Q2 | 512.8 Million USD | 9.5% |
| 2018 Q4 | 409 Million USD | 10.51% |
| 2018 FY | 409 Million USD | 69.57% |
| 2018 Q1 | 283.6 Million USD | 17.58% |
| 2018 Q2 | 331.5 Million USD | 16.89% |
| 2018 Q3 | 370.1 Million USD | 11.64% |
| 2017 Q1 | 213.5 Million USD | 17.11% |
| 2017 Q4 | 241.2 Million USD | 7.1% |
| 2017 Q3 | 225.2 Million USD | 5.14% |
| 2017 Q2 | 214.2 Million USD | 0.33% |
| 2017 FY | 241.2 Million USD | 32.31% |
| 2016 Q4 | 182.3 Million USD | -0.65% |
| 2016 Q2 | 169.2 Million USD | 3.8% |
| 2016 Q1 | 163 Million USD | -2.92% |
| 2016 FY | 182.3 Million USD | 8.58% |
| 2016 Q3 | 183.5 Million USD | 8.45% |
| 2015 Q3 | 194 Million USD | -3.63% |
| 2015 Q4 | 167.9 Million USD | -13.45% |
| 2015 Q1 | 202.4 Million USD | 11.39% |
| 2015 FY | 167.9 Million USD | -7.59% |
| 2015 Q2 | 201.3 Million USD | -0.54% |
| 2014 Q3 | 198.9 Million USD | -1.73% |
| 2014 Q1 | 185.5 Million USD | 3.29% |
| 2014 Q4 | 181.7 Million USD | -8.65% |
| 2014 FY | 181.7 Million USD | 1.17% |
| 2014 Q2 | 202.4 Million USD | 9.11% |
| 2013 Q4 | 179.6 Million USD | -10.24% |
| 2013 Q3 | 200.1 Million USD | 18.19% |
| 2013 Q2 | 169.3 Million USD | 24.94% |
| 2013 Q1 | 135.5 Million USD | 11.52% |
| 2013 FY | 179.6 Million USD | 47.82% |
| 2012 FY | 121.5 Million USD | 8.39% |
| 2012 Q4 | 121.5 Million USD | -3.42% |
| 2012 Q3 | 125.8 Million USD | 5.36% |
| 2012 Q2 | 119.4 Million USD | 0.51% |
| 2012 Q1 | 118.8 Million USD | 5.98% |
| 2011 Q3 | 108.6 Million USD | 8.49% |
| 2011 Q1 | 93.3 Million USD | 7.49% |
| 2011 FY | 112.1 Million USD | 29.15% |
| 2011 Q4 | 112.1 Million USD | 3.22% |
| 2011 Q2 | 100.1 Million USD | 7.29% |
| 2010 Q3 | 85 Million USD | 14.86% |
| 2010 FY | 86.8 Million USD | 50.69% |
| 2010 Q4 | 86.8 Million USD | 2.12% |
| 2010 Q2 | 74 Million USD | 8.03% |
| 2010 Q1 | 68.5 Million USD | 18.92% |
| 2009 Q1 | 64.38 Million USD | 1.45% |
| 2009 Q4 | 57.6 Million USD | 1.68% |
| 2009 FY | 57.6 Million USD | -9.23% |
| 2009 Q3 | 56.64 Million USD | -4.39% |
| 2009 Q2 | 59.24 Million USD | -7.98% |
| 2008 FY | 63.46 Million USD | 95.77% |
| 2008 Q4 | 63.46 Million USD | 20.88% |
| 2008 Q3 | 52.49 Million USD | 23.25% |
| 2008 Q2 | 42.59 Million USD | 9.69% |
| 2008 Q1 | 38.83 Million USD | 19.79% |
| 2007 Q1 | 26.26 Million USD | 8.09% |
| 2007 Q4 | 32.41 Million USD | 21.08% |
| 2007 FY | 32.41 Million USD | 33.43% |
| 2007 Q3 | 26.77 Million USD | 11.37% |
| 2007 Q2 | 24.04 Million USD | -8.46% |
| 2006 Q2 | 24.63 Million USD | 20.96% |
| 2006 FY | 24.29 Million USD | 60.15% |
| 2006 Q3 | 22.33 Million USD | -9.37% |
| 2006 Q4 | 24.29 Million USD | 8.8% |
| 2006 Q1 | 20.36 Million USD | 34.26% |
| 2005 Q3 | 12.22 Million USD | 38.3% |
| 2005 Q2 | 8.83 Million USD | 16.79% |
| 2005 Q1 | 7.56 Million USD | 26.82% |
| 2005 FY | 15.17 Million USD | 154.27% |
| 2005 Q4 | 15.17 Million USD | 24.14% |
| 2004 Q3 | 6.59 Million USD | -7.9% |
| 2004 FY | 5.96 Million USD | -32.11% |
| 2004 Q1 | 7.98 Million USD | -9.16% |
| 2004 Q4 | 5.96 Million USD | -9.55% |
| 2004 Q2 | 7.16 Million USD | -10.28% |
| 2003 Q4 | 8.78 Million USD | -31.05% |
| 2003 Q2 | 13.6 Million USD | 64.22% |
| 2003 Q1 | 8.28 Million USD | -5.22% |
| 2003 Q3 | 12.74 Million USD | -6.29% |
| 2003 FY | 8.78 Million USD | 0.57% |
| 2002 Q4 | 8.73 Million USD | -11.48% |
| 2002 Q2 | 7.23 Million USD | 15.83% |
| 2002 Q1 | 6.24 Million USD | 0.97% |
| 2002 FY | 8.73 Million USD | 41.35% |
| 2002 Q3 | 9.87 Million USD | 36.53% |
| 2001 Q2 | 6.79 Million USD | 4.11% |
| 2001 FY | 6.18 Million USD | 1.74% |
| 2001 Q4 | 6.18 Million USD | -18.6% |
| 2001 Q3 | 7.59 Million USD | 11.84% |
| 2001 Q1 | 6.52 Million USD | 7.36% |
| 2000 Q1 | 3.57 Million USD | 0.0% |
| 2000 Q4 | 6.07 Million USD | 15.6% |
| 2000 Q3 | 5.25 Million USD | 9.59% |
| 2000 Q2 | 4.79 Million USD | 34.23% |
| 2000 FY | 6.07 Million USD | 112.37% |
| 1999 FY | 2.86 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -6727.768% |
| AngioDynamics, Inc. | 60.61 Million USD | -1913.66% |
| AtriCure, Inc. | 67.89 Million USD | -1697.723% |
| Avinger, Inc. | 5.29 Million USD | -22938.883% |
| Azenta, Inc. | 128.19 Million USD | -852.121% |
| BioLife Solutions, Inc. | 43.45 Million USD | -2708.818% |
| The Cooper Companies, Inc. | 735.6 Million USD | -65.933% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -24070.297% |
| Femasys Inc. | 667.11 Thousand USD | -182866.132% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -4838.501% |
| Hologic, Inc. | 679.8 Million USD | -79.553% |
| ICU Medical, Inc. | 709.36 Million USD | -72.071% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -34961.605% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | -2232.372% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -142367.135% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -142367.135% |
| Masimo Corporation | 545 Million USD | -123.963% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -75374.965% |
| Merit Medical Systems, Inc. | 303.87 Million USD | -301.684% |
| Nephros, Inc. | 2.47 Million USD | -49317.004% |
| NovoCure Limited | 38.15 Million USD | -3099.308% |
| NEXGEL, Inc. | 1.31 Million USD | -92439.803% |
| NEXGEL, Inc. | 1.31 Million USD | -92439.803% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -8893.516% |
| OraSure Technologies, Inc. | 47.61 Million USD | -2463.532% |
| Pro-Dex, Inc. | 15.26 Million USD | -7893.975% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -246798.097% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -42457.791% |
| QuidelOrtho Corporation | 577.8 Million USD | -111.25% |
| Repligen Corporation | 202.32 Million USD | -503.299% |
| Sanara MedTech Inc. | 4.71 Million USD | -25773.693% |
| STAAR Surgical Company | 35.13 Million USD | -3374.523% |
| Sharps Technology, Inc. | 1.7 Million USD | -71316.243% |
| Utah Medical Products, Inc. | 9.58 Million USD | -12638.468% |
| DENTSPLY SIRONA Inc. | 624 Million USD | -95.609% |
| Jin Medical International Ltd. | 5.05 Million USD | -24055.297% |